期刊文献+

RGD修饰包载超顺磁性氧化铁纳米粒用于脑胶质瘤的靶向研究 被引量:2

RGD Modified Super Paramagnetic Iron Oxide Loaded Nanoparticles for Glioma Targeting
原文传递
导出
摘要 目的:采用PLGA-PEG为聚合材料,制备RGD修饰包载超顺磁性四氧化三铁纳米粒子(RGD-NP-Fe3O4),用于脑胶质瘤细胞靶向核磁共振成像纳米探针。方法:采用沉淀法制备RGD修饰的载超顺磁性纳米粒,考察纳米粒的粒径,电位等理化指标以及细胞毒性。通过细胞以及肿瘤球摄取实验,考察RGD-NP-Fe3O4的脑胶质瘤细胞靶向性。结果:制备得到的RGD-NP-Fe3O4粒径在85±7.5 nm,电位为18±1.15 mV。纳米粒浓度在300μg/mL范围内,对脑胶质瘤细胞均无显著毒性。经过RGD修饰后脑胶质瘤细胞U87对纳米粒的摄取效率大大提高,纳米粒穿透肿瘤球能力显著增强。结论:RGD修饰包载超顺磁性氧化铁纳米粒是一种潜在的高效的脑胶质瘤细胞靶向诊断纳米探针和靶向给药系统。 Objective: To prepare the RGD-NP-Fe3O4 with the materials of PLGA-PEG for the nano probe of the nuclear magnetic resonance imaging for targeted glioma cells. Methods: The nano was prepared by the method of precipitation. The size of the nano particles, the physical and chemical index and the cell toxicity were inspected. The targeting efficiency was evaluated by U87 cellular uptake and tumor spheroids. Results: The particle diameter of RGD-NP-Fe3O4 was 85~ 7.5 nm with the Zeta potential of 18± 1.15 mV. The result demonstrated that the RGD-NP-Fe3O4 could be taken up by U87 with 2.7 times which was higher than that of the NP-Fe3O4. The evaluation of tumor spheroid penetration shows RGD-NP-Fe3O4 has the strongest fluorescence intensity. Conclusions: RGD-NP- Fe3O4 is a potential effective drug delivery system for glioma diagnose and treatment.
出处 《现代生物医学进展》 CAS 2013年第35期6814-6817,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81101604)
关键词 RGD 超顺磁性四氧化三铁 脑胶质瘤 靶向 RGD Uper paramagnetic iron oxide Glioma Targeting
  • 相关文献

参考文献1

共引文献13

同被引文献58

  • 1Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 [J]. Neuro Oncol, 2015, 17 Suppl 4: ivl-iv62, doi: 10,1093/neuonc/nov189.
  • 2Ellis HP, Greenslade M, Powell B, et al. Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Dis- ease, and Models to Predict Disease Recurrence [J]. Front Oncol, 2015, 5: 251. doi: 10.3389/fonc,2015.00251.
  • 3Lima FR, Kahn SA, Soletti RC, et al. Glioblastoma: therapeutic challenges, what lies ahead [J]. Biochim Biophys Acta, 2012, 1826(2): 338-349. doi: 10,1016/ j.bbcan,2012.05.004.
  • 4Champ CE, Siglin J, Mishra MV, et al. Evaluating changes in radiation treatment volumes from post-operative to same- day planning MRI in High-grade gliomas [J]. Radiat Oncol, 2012, 7: 220. doi: 10,1186/1748-717X-7-220.
  • 5Chen S, Tanaka S, Giannini C, et al. Gliomatosis cerebri: clinical characteristics, management, and outcomes [J]. J Neurooncol, 2013, 112(2): 267-275. doi: 10,1007/sl 1060- 013-1058-x.
  • 6Zhan C, Li B, Hu L, et al. Micelle-based brain-targeted drug delivery enabled by a nicotine acetylcholine recep- tor ligand [J]. Angew Chem Int Ed Engl, 2011, 50(24): 5482-5485. doi: 10,1002/anie,201100875.
  • 7Lu W, Wan J, She Z, et al. Brain delivery property and ac- celerated blood clearance of cationic albumin conjugated pegylated nanoparticle [J]. J Control Release, 2007, 118(1): 38-53.
  • 8Bolhassani A. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer [J]. Biochim Biophys Acta, 2011, 1816(2): 232-246. doi: 10,1016/ j.bbcan,2011.07.006.
  • 9Chen X, Plasencia C, Hou Y, et al. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery [J]. J Med Chem, 2005, 48(4): 1098-1106.
  • 10Zhan C, Gu B, Xie C, et al. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect [J]. J Control Release, 2010, 143(1): 136-142. doi: 10,1016/j.jconrel,2009,12.020.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部